Effects of Expiratory Pressure on Arterial Oxygenation During Hypoxia (hypex)

February 27, 2012 updated by: AGIR à Dom

Arterial Oxygenation During Hypoxia : Effects of an Added Expiratory Resistance

Altitude tolerance correlates with the level of oxygenation achieved. The aim of the present study is to investigate whether increased expiratory pressure within the thorax is able to improve oxygenation during hypoxic hypoxia.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Two types of procedures will be tested in a random order, interspaced by resting periods : threshold PEEP set at 5,10 and 15 cm of water and pursed leap breathing.

Subjects will be tested at rest, and during light exercise (30% of sea level predicted VO2max).

FiO2 will be set at 12.5% (4000 m). fc, VE, PETCO2, TA, ECG, cardiac output, and tissular oxygenation will be monitored.

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Isere
      • La Tronche, Isere, France, 38000
        • Recruiting
        • CHU de Grenoble
        • Contact:
        • Contact:
        • Principal Investigator:
          • Bernard Wuyam, MD, PhD
        • Sub-Investigator:
          • Samuel Vergès, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

community sample with mounteneering experience

Description

Inclusion Criteria :

  • active (> 2 hrs/week physical activity)
  • adult
  • non smoking volunteers

Exclusion Criteria :

  • cardiac, respiratory, neuromuscular, metabolic pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
healthy active subjects
with and without high altitude intolerance
Various set of pressures : 0, 5, 10 cm H20; pursed lips breathing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SpO2
Time Frame: mean over 1 minute
after three minutes of PEEP vs spontaneous breathing
mean over 1 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
peripheral HbO2/DeoxyHb
Time Frame: 1 min
after three minutes of PEEP / PLB vs. spontaneous breathing
1 min
cardiac output
Time Frame: mean over 1 min
after three min of PEEP vs. spontaneous breathing
mean over 1 min
pattern of breathing (fR, VT, PETCO2)
Time Frame: 1 min
after three min of PEEP vs. spontaneous breathing
1 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Bernard Wuyam, MD, PhD, University Hospital, Grenoble
  • Study Director: Samuel Vergès, PhD, Institut National de la Santé Et de la Recherche Médicale, France
  • Study Chair: Hugo NESPOULET, MsC, Université Joseph Fourier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Study Registration Dates

First Submitted

December 14, 2010

First Submitted That Met QC Criteria

December 14, 2010

First Posted (Estimate)

December 15, 2010

Study Record Updates

Last Update Posted (Estimate)

February 28, 2012

Last Update Submitted That Met QC Criteria

February 27, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 10-AGIR-2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypoxia

Clinical Trials on threshold PEEP

3
Subscribe